FCMC
Founders Capital Management (Connecticut) Portfolio holdings
AUM
$587M
This Quarter Return
+3.08%
1 Year Return
+14.61%
3 Year Return
+78.24%
5 Year Return
+130.13%
10 Year Return
+277.82%
AUM
$200M
AUM Growth
+$200M
(+2.4%)
Cap. Flow
-$1.02M
Cap. Flow
% of AUM
-0.51%
Top 10 Holdings %
Top 10 Hldgs %
52.78%
Holding
56
New
1
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
UnitedHealth
UNH
|
$205K |
| 2 |
DaVita
DVA
|
$33.7K |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$1.21M |
| 2 |
Procter & Gamble
PG
|
$51K |
Sector Composition
| 1 | Healthcare | 21.85% |
| 2 | Industrials | 18.34% |
| 3 | Financials | 14.9% |
| 4 | Technology | 13.51% |
| 5 | Consumer Staples | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Bristol-Myers Squibb
BMY
$97.1B
| $230K | 0.11% |
4,097
| – | – |
|
52
DuPont de Nemours
DD
$31.7B
| $206K | 0.1% |
3,253
| – | – |
|
|
53
UnitedHealth
UNH
$277B
| $205K | 0.1% |
+1,108
| New | +$205K |
|
|
BHI
54
DELISTED
Baker Hughes
BHI
| $203K | 0.1% |
3,717
| – | – |
|
55
Enterprise Products Partners
EPD
$69B
| $191K | 0.1% |
7,057
| – | – |
|
|
56
Gilead Sciences
GILD
$140B
| – | – |
-17,777
| Closed | -$1.21M |
|